BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Amniocentesis
,
Doxorubicin
,
rs2300478
,
SLC12A1
,
Response to oxidative stress
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
HER 2/ neu
Summary
General Info
Curated Studies
Most Correlated Studies
NF639 with EGCG-resistance expression profiling
Breast cancer cells treated with Withaferin A
Blood monocytes pooled from mice with homozygous CCL2 or CCR2 gene knockout
Mammary carcinoma N202.1A cells adapted to growth on brain, lung, bone marrow or breast tissue
Explore Curated Studies Results
Literature
Most Relevant Literature
Prevention of mammary carcinogenesis in MMTV-neu mice by targeting RLIP.
RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-dir…
PRESSING Need of Precision Care in HER2-Positive Colorectal Cancer: The ELEPHANT in the Room.
Advances in the treatment of anti-HER-2 antibody drug conjugates in pan-tumor with low HER-2 express…
Current Management and Future Perspectives in Metastatic HER2-Positive Breast Cancer.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU
Paclitaxel With or Without Trastuzumab in Treating Patients With or Without HER-2/Neu Breast Cancer …
Pilot Trial of HER-2/Neu Pulsed DC1 Vaccine for Patients With HER-2 Positive Metastatic Cancer
Trastuzumab, Cyclophosphamide, and an Allogeneic GM-CSF-secreting Breast Tumor Vaccine for the Treat…
Myocet, Docetaxel & Trastuzumab as 1st Line Treatment of Patients With HER-2/Neu Positive Metastatic…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ